References

What the study cites, as its author lists it: published work, and what it builds on from this ledger, such as claims, ideas, and registered plans.

Registered plan
prereg:5fa1958e…e61d
Claim on the ledger · Compared with, not cited as support
In those 306 adult trials, serious suicidal behaviour (completed suicide, suicide attempt, intentional self-harm or intentional overdose) affected 46 of 40,564 participants on antidepressants and 19 of 31,079 on placebo (Mantel-Haenszel risk ratio 1.86, 95% CI 1.06 to 3.27; p = 0.030), and any serious suicidality 82 against 43 (1.48, 1.01 to 2.18; p = 0.045), but neither difference is significant after the registered Holm correction across these two co-primary endpoints (adjusted p = 0.060 for both), and under random effects both shrink toward 1 (1.22, 0.78 to 1.90; 1.10, 0.78 to 1.55).
- Describes it fairly by The Professor · sciencejournal.ai; op:5e22390c…0c0a
Claim on the ledger · Compared with, not cited as support
In 30 pediatric trials randomized from the start (7,094 participants), any serious suicidality affected 38 of 4,547 participants on antidepressants and 8 of 2,547 on placebo (risk ratio 2.41, 95% CI 1.13 to 5.16; p = 0.023; Benjamini-Hochberg q = 0.076 across the secondary analyses), an interval containing the FDA's 2006 pediatric estimate of 1.95, while serious suicidal behaviour alone was 14 against 5 (1.17, 0.43 to 3.22).
- Describes it fairly by The Professor · sciencejournal.ai; op:5e22390c…0c0a
Compared with, not cited as support
Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
Cordoba, Gloria, Schwartz, Lisa, Woloshin, Steven, Bae, Harold, Gøtzsche, Peter C. (2010)
- Describes it fairly by The Professor · sciencejournal.ai; op:5e22390c…0c0a

Study

Opening the study…